期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Validation of neuropathic pain assessment tools among Chinese patients with painful diabetic peripheral neuropathy 被引量:4
1
作者 Jiali Chen Li Li 《International Journal of Nursing Sciences》 2016年第2期139-145,共7页
Objective:This study aims to evaluate the reliability and validity of neuropathic pain assessment tools among Chinese patients with painful diabetic peripheral neuropathy(PDPN).Methods:One hundred patients with PDPN a... Objective:This study aims to evaluate the reliability and validity of neuropathic pain assessment tools among Chinese patients with painful diabetic peripheral neuropathy(PDPN).Methods:One hundred patients with PDPN and 70 patients with non-neuropathic pain were recruited from five grade III general hospitals in Guangzhou.Pain was assessed using the Leeds Assessment of Neuropathic Symptoms and Signs(LANSS),Douleur Neuropathique 4 questionnaire(DN4),and Brief Pain Inventory for Painful Diabetic Peripheral Neuropathy(BPI-DPN).Reliability was evaluated by internal consistency of the Cronbach's a coefficient and Guttman split-half.Construct validity was analyzed by factor analysis and Spearman correlation coefficients.Sensitivity and specificity were also assessed.Results:The Cronbach's a coefficients of the LANSS,DN4,and BPI-DPN were 0.735,0.750,and 0.898,respectively.The Guttman split-half coefficients of the LANSS,DN4,and BPIDPN were 0.660,0.726,and 0.849,respectively.The cumulative contributions of the LANSS,DN4,and BPI-DPN to the total variance were 61.945%,57.010%,and 66.056%,respectively.The items of the LANSS,DN4,and BPI-DPN presented high factorial loads,ranging from 0.387 to 0.841,0.137 to 0.948,and 0.487 to 0.953,respectively.The LANSS and DN4 exhibited sensitivities of 58.0%and 82.7%,respectively,and specificity of 97.1%.Conclusions:The LANSS or DN4 can be used to detect neuropathic pain in Chinese patients with PDPN.The BPI-DPN can be employed to monitor the effectiveness of pain intervention. 展开更多
关键词 brief pain inventory for painful diabetic peripheral neuropathy Douleur neuropathique 4 QUESTIONNAIRE Leeds assessment of neuropathic symptoms and signs painful diabetic peripheral neuropathy Reliability Validity
下载PDF
消渴痛痹方治疗痛性糖尿病周围神经病变的临床研究 被引量:1
2
作者 梁庆顺 刘昀玮 +5 位作者 李安香 卢绮韵 陶一鸣 刘振杰 罗露露 吴丽燕 《北京中医药大学学报》 CAS CSCD 北大核心 2023年第11期1554-1560,共7页
目的探讨消渴痛痹方治疗痛性糖尿病周围神经病变(PDPN)的临床疗效。方法选择2018年8月—2020年12月在广东省中医院就诊的痛性糖尿病周围神经病变患者68例,按随机数字表法分为对照组和观察组,每组34例。剔除脱落病例后,对照组31例,观察... 目的探讨消渴痛痹方治疗痛性糖尿病周围神经病变(PDPN)的临床疗效。方法选择2018年8月—2020年12月在广东省中医院就诊的痛性糖尿病周围神经病变患者68例,按随机数字表法分为对照组和观察组,每组34例。剔除脱落病例后,对照组31例,观察组29例。对照组给予普瑞巴林,观察组给予消渴痛痹方,治疗10周。主要评价指标为糖尿病周围神经病变简明疼痛量表(BPI-DPN)评分,次要评价指标为疼痛11点数字评分法(NRS-11)评分、睡眠干扰评分日记(DSID)评分、患者总体印象变化(PGIC)评分、中医证候积分、感觉神经传导速度(SNCV)、运动神经传导速度(MNCV)与不良反应。结果与对照组相比,观察组BPI-DPN评分总有效率为75.9%,高于对照组的54.8%(P=0.019);PGIC评分总有效率为44.8%,高于对照组的9.7%(P=0.002);中医证候积分总有效率为58.6%,高于对照组的41.9%(P=0.049)。观察组治疗期间未发生不良事件,对照组出现头晕、嗜睡、双下肢无力等不良事件,差异有统计学意义(P<0.05)。结论消渴痛痹方能明显改善痛性糖尿病周围神经病变患者的临床症状和生活质量,且具有良好的安全性。 展开更多
关键词 痛性糖尿病周围神经病变 消渴痛痹方 普瑞巴林 神经功能 糖尿病周围神经病变简明疼痛量表
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部